ah 6809 has been researched along with cp533536 in 1 studies
| Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (cp533536) | Trials (cp533536) | Recent Studies (post-2010) (cp533536) |
|---|---|---|---|---|---|
| 163 | 1 | 49 | 12 | 0 | 4 |
| Protein | Taxonomy | ah 6809 (IC50) | cp533536 (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganesh, T | 1 |
1 review(s) available for ah 6809 and cp533536
| Article | Year |
|---|---|
Prostanoid receptor EP2 as a therapeutic target.
Topics: Animals; Anti-Inflammatory Agents; Eye Diseases; Gene Knockout Techniques; Humans; Molecular Targeted Therapy; Neurodegenerative Diseases; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Stroke | 2014 |